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Abstract
A resistance of A/H1N1 influenza viruses to oseltamivir has recently emerged in a number of countries. However,
the clinical and socioeconomic importance of this resistance has not been precisely defined. As children have the
highest incidence of influenza infection and are at high risk of severe disease, the aim of this study was to evaluate
the clinical importance and the impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus
in an otherwise healthy pediatric population. A total of 4,726 healthy children younger than 15 years with influ-
enza-like illness were tested for influenza viruses by real-time polymerase chain reaction in the winters of 2007-
2008 and 2008-2009 in Italy. The influenza A virus-positive samples underwent neuraminidase gene analysis using
pyrosequencing to identify mutations H275Y and N294 S in A/H1N1, and E119V, R292K, and N294 S in A/H3N2.
Among the A/H1N1 subtypes, the H275Y mutation was found in 2/126 samples taken in 2007-2008 (1.6%) and in
all 17 samples (100%; p < 0.0001) taken in 2008-2009. No other mutation was identified in any of the A/H1N1 or
A/H3N2 influenza viruses. No significant differences were found in terms of clinical importance or impact on the
households between the children with oseltamivir-resistant seasonal A/H1N1 influenza virus and those with the
wild-type. The spread of H275Y-mutated A/H1N1 seasonal influenza virus is a common phenomenon and the clini-
cal importance and impact on the households of the mutated virus is similar to that of the wild-type in an other-
wise healthy pediatric population.
Finding
Type A influenza viruses are the major cause of influenza
worldwide, and subtype A/H1N1 is the most frequently
found in the younger population [1,2]. A resistance of A/
H1N1 influenza viruses to oseltamivir (mainly due to the
H275Y mutation) has recently emerged in a number of
countries [3-6]. Oseltamivir-resistant viruses have been
associated with a negative disease course and death in
high-risk patients [7-9], but there are few data concern-
ing the otherwise healthy population. As children have
the highest incidence of influenza infection and are at
high risk of severe disease when infected by wild-type
influenza viruses, the aim of this study was to evaluate
the clinical importance and impact on the households of
oseltamivir-resistant seasonal A/H1N1 influenza virus in
an otherwise healthy pediatric population.
This multicentre prospective study was carried out in
the winters of 2007-2008 and 2008-2009 (from 1
November to 31 March) in the Emergency Room (ER)
of five children’s hospitals in Italy (Milan, Padua, Genoa,
Naples and Bari). The study protocol was approved by
the Institutional Review Board of each participating cen-
tre; the written informed consent of a parent or legal
guardian was required, and the older children were
asked for their assent.
The study enrolled subjects aged less than 15 years and
without any underlying chronic severe disease who
attended an ER for an influenza-like illness as defined by
the Italian Ministry of Health http://www.ministerosalute.
it. During winter 2007-2008, enrolment took place on two
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days per week (Wednesday and Sunday); during winter
2008-2009, it took place every day. In both seasons, the
enrolled patients’ demographic characteristics and medical
history were systematically recorded using standardised
written questionnaires as previously described [10,11] and,
after a complete physical examination, they were classified
into disease groups on the basis of signs and/or symptoms
using well-established criteria [12].
A nasopharyngeal sample was collected from all of the
children using a pernasal flocked swab, and stored in a
tube of UTM-RT (Kit Cat. No. 360c, Copan Italia, Brescia,
Italy). Each sample underwent real-time polymerase chain
reaction (real-time PCR) in order to identify A and B
influenza viruses as previously described [7,13]. Reverse
transcription plates were set up for subtyping using a Qia-
gility robot (Qiagen, West Sussex, UK), and multiplex
real-time PCR was performed using a Taqman Fast Uni-
versal PCR Master Mix (Applied Biosystems, Warrington,
UK), fast cycling conditions, and the following primers-
probes on an ABI 7500 Fast instrument (Applied Biosys-
tems, Warrington, UK) (final concentrations in parenth-
eses): A/H1-forward GGAATAGC CCCCCTACAATTG
(1 μM); A/H1-reverse AATTCGCATTCTGGGTTT
CCTA (1 μM); A/H1 probe NED-CGTTGCC-GGATG-
GAMGBNFQ (0.05 μM); A/H3-forward CCTTTTTG
TTGAACGCA-GCAA (1 μM); A/H3-reverse CGGAT-
GAGGCAACTAGTGACCTA (1 μM); A/H3-probe VIC-
CCTACAGC-AACTGTTACCMG BNFQ (0.25 μM);
B-forward TCACGAAAAATACGGT GGATTAAA
(0.75 μM); B-reverse TTTGGTTCCA TTGGCMAGCT
(0.75 μM); B-probe 6FAM-CCAATATGGGTGAAAA
CMG BNFQ (0.3 μM).
The A influenza virus-positive samples underwent
neuraminidase gene analysis using pyrosequencing to
identify mutations H275Y and N294 S in A/H1N1, and
E119V, R292K, and N294 S in A/H3N2. Reverse-tran-
scription (RT) PCR was performed on viral RNA using
the Qiagen One-Step RT-PCR Kit with using 0.6 μM
primer concentrations. The pyrosequencing was per-
formed as previously described [14]. The primers used
for PCR and pyrosequencing were N1 275-294 forward
GGAGCCGTGGCTGTACTAAAATA; N1 275-294-
reverse BIOTIN-CCACGTTTTGATTAAAAGACACC;
N1 275-sequence AGTTGAATGCACCCAAT; N1 294-
sequence TGTGTGTATGCAGGGAC; N2 119-forward
TTTTATCTGACCAACACCACCATAGAG; N2 119-
reverse BIOTIN-CGCTAAGGGGTCCTATCATG-
TACT; N2 119-sequence ACATCTGGGTGACAAGA;
N2 292-294-forward BIOTIN-TTCATTGAGGAGGG-
GAAAA; N2 292-294-reverse GATCAACGCAATGGC-
TACTG; N2 292-294-sequence GCCTATTGG
AGCCTT.
The children’s medical history was re-evaluated 5-7
days after enrolment, and until the resolution of their
illness, by means of interviews and clinical examinations
conducted by trained investigators using standardised
questionnaires that also collected information regarding
household illnesses and related morbidities [10,11]. All
of the data relating to the study children and their
households were verified from medical records.
Continuous data were analysed using a two-sided Stu-
dent’s t-test, after checking data were normally distribu-
ted (based on the Shapiro-Wilk statistic) and a two-
sided Wilcoxon’s rank-sum test otherwise. Categorical
data were analysed using the contingency table analysis
with the Chi-square or Fisher’s test, as appropriate.
With a 5% type 1 error rate and a power of 80%, 17
subjects in the group of oseltamivir-resistant virus and
85 in the group of wild-type virus were required to
show a difference of 30% in the severity of influenza-
related events.
A total of 4,726 children (2,599 males; mean age ±
standard deviation [SD], 3.34 ± 3.06 years) were
enrolled: 1,170 (24.8%) during winter 2007-2008 and
3,556 (75.2%) during winter 2008-2009. Influenza A
viruses were detected in 729 (15.4%) children, 164/1,170
(14.0%) in the first year and 565/3,556 (15.9%) in the
second; influenza B viruses were detected in 239 (5.1%),
179/1,170 (15.3%) in 2007-2008 and 60/3,556 (1.7%; p <
0.0001) in 2008-2009. In the two seasons, none of the
influenza A or B positive children has been previously
vaccinated against influenza.
Influenza A viruses in 150 of the 164 sample collected
in the first year (91.5%) and 512 of the 565 samples col-
lected in the second year (90.6%) were subtyped and
analysed using pyrosequencing. Subtype A/H1N1 was
identified in respectively 126/150 (84%) and 17/512
cases (3.3%; p < 0.0001), and subtype A/H3N2 in 24/150
(16%) and 495/512 (96.7%; p < 0.0001). Among the
A/H1N1 subtypes, the H275Y mutation was found in
2/126 samples (1.6%) in 2007-2008 and in all 17 samples
(100%; p < 0.0001) in 2008-2009. No difference in resis-
tance frequency was observed between the different cen-
ters during both seasons. No other mutation was
identified in any of the A/H1N1 or A/H3N2 influenza
viruses.
Table 1 shows the demographic and clinical character-
istics of the children with A/H1N1 influenza infection,
by the presence or absence of the H275Y mutation, and
the impact on the households of the infection on their
households No statistically significant differences were
found in terms of gender, age, viral load, diagnosis at
enrolment, clinical outcome, pharmacological treatment
or impact on the households between the children with
oseltamivir-resistant seasonal A/H1N1 influenza virus
and those with the wild-type.
The findings of this study show that the spread of
H275Y-mutated A/H1N1 seasonal influenza virus is a
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common phenomenon that may be unrelated to the pre-
vious use of antivirals, and that the clinical importance
and impact on the households of the mutated virus is
similar to that of the wild-type in an otherwise healthy
pediatric population.
The presence of mutated viruses was marginal in win-
ter 2007-2008, but increased to 100% in the following
year even though the use of neuraminidase inhibitors
remained minimal in Italy and was not reported in our
patients. Due to the lower incidence of A/H1N1 influ-
enza virus in our population during winter 2008-2009
than in the previous year, a small group of children with
mutated strains was identified. However, the presence of
the H275Y mutation did not seem to modify the patho-
genicity of A/H1N1 influenza virus in our otherwise
healthy children because all the variables evaluated for
the clinical importance and impact on the households of
the infections due to mutated or wild-type viruses were
comparable. This finding is in line with data coming
from national surveillance systems in Europe and the
United States [3-6], and suggests that pediatricians do
not need to search for this mutation in healthy children
with mild to moderate disease.
There have been recent reports concerning the nega-
tive evolution of oseltamivir-resistant A/H1N1 influenza
[7-9]. However, most of these cases involved subjects
with underlying severe chronic diseases, and it is possi-
ble that the reduction in host defences due to their
underlying condition favoured prolonged viral shedding
and the development of severe influenza, as frequently
occurs in cases due to wild-type influenza virus. It is
also possible that, in cases with a negative evolution, the
H275Y mutation may be associated with one or more
other genetic mutations. We found only the H275Y
mutation in our children who developed mild or moder-
ate influenza, whereas complete sequencing of the neur-
aminidase gene in adult and elderly patients with severe
disease by Goosken et al. demonstrated the presence of
a second mutation, the T284A substitution [8]. Further-
more, it has been reported that a number of different
mutations conferring various degrees of resistance, such
as H126N G248R, S247N or S247G, can be found
Table 1 Demographic, clinical and socioeconomic characteristics of the children with A/H1N1 influenza infection, by
the presence or absence of the H275Y mutation.
Characteristics Oseltamivir-resistant seasonal A/H1N1
influenza virus (n = 19)
Wild-type seasonal A/H1N1 influenza
virus (n = 124)
Demographic data
No. of males (%) 11 (57.9) 73 (58.9)
Mean age ± SD, years 4.33 ± 3.61 3.39 ± 2.58
Previous use of neuraminidase inhibitors, no. (%) 0 (0.0) 0 (0.0)
CT, mean ± SD 25.48 ± 4.44 26.94 ± 4.57
Clinical presentation
Common cold, No. (%) 4 (21.0) 28 (22.6)
Pharyngitis, No. (%) 5 (26.3) 34 (27.4)
Acute otitis media, No. (%) 3 (15.8) 18 (14.5)
Acute bronchitis, No. (%) 4 (21.0) 26 (21.0)
Pneumonia, No. (%) 1 (5.3) 8 (6.5)
Gastroenteritis, No. (%) 1 (5.3) 6 (4.8)
Fever without source, No. (%) 1 (5.3) 4 (3.2)
Clinical outcome
Hospitalisation, No. (%) 4 (21.0) 21 (16.9)
Median number of lost school days (range) 6 (1-12) 5 (1-10)
Pharmacological treatment
Antibiotics, No. (%) 13 (68.4) 88 (70.9)
Antivirals, No. (%) 0 (0.0) 0 (0.0)
Antipyretics, No. (%) 16 (84.2) 99 (79.8)
Socioeconomic impact on households
Similar disease among family members, No. (%) 10 (52.6) 52 (41.9)
Hospitalisations, No. (%) 1 (5.3) 0 (0.0)
Median number of lost parental working days (range) 3 (1-11) 3 (1-9)
Median number of lost sibling working days, (range) 4 (2-14) 3 (2-15)
CT, cycle thresold; SD, standard deviation. No significant between-group differences.
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among resistant A/H1N1 influenza strains [5,6], and
that the presence of the D344N substitution in neurami-
nidase is associated with an increase in enzyme activity
[15]. All of these data suggest that the risk of severe
influenza in subjects with oseltamivir-resistant A/H1N1
virus may be related to the type and number of
mutations.
In conclusion, despite its frequency, A/H1N1 influenza
virus with a single H275Y mutation is of marginal clini-
cal importance and impact on the households in other-
wise healthy children, but further studies are needed to
clarify its role in children with severe influenza, as well
as the relationships between different mutations and
complicated clinical pictures.
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